1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Dyslipidemias in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Present study was conducted to investigate the effects of rosuvastatin combined with fasudil on rabbits with dyslipidemia." | 7.81 | Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia. ( Li, Z; Lian, H; Liang, Q; Zeng, F; Zheng, D, 2015) |
| "Present study was conducted to investigate the effects of rosuvastatin combined with fasudil on rabbits with dyslipidemia." | 3.81 | Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia. ( Li, Z; Lian, H; Liang, Q; Zeng, F; Zheng, D, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z | 1 |
| Lian, H | 1 |
| Liang, Q | 1 |
| Zeng, F | 1 |
| Zheng, D | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Dyslipidemias
| Article | Year |
|---|---|
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Drug Therapy, Combination; Dyslipidemias; Ma | 2015 |